Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279.
about
Neuronal deletion of GSK3β increases microtubule speed in the growth cone and enhances axon regeneration via CRMP-2 and independently of MAP1B and CLASP2.GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animalsDysregulation of tau phosphorylation in mouse brain during excitotoxic damageDemonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.Deconstructing GSK-3: The Fine Regulation of Its Activity.Role and regulation of Glycogen synthase kinase-3 beta in bovine spermatozoa.
P2860
Q30597608-5B5E1B8F-AE94-4C79-B353-6AD2CB3FF467Q30619452-47929699-56EE-4A13-A763-615EAC6A7348Q33691114-0EE507FA-883C-40A1-B9DE-D9B2CAFC6CC3Q35858095-F6D74337-5702-440E-9BE5-18C13F7578C7Q37946881-8625DEB7-B9DF-4697-802F-E2444A5152BDQ39118317-079DC477-62E7-46F3-97F6-9EB231D8982DQ39584289-FD340A2C-A829-41DD-A96E-5472E6CCEA31Q42135408-DF1FAD68-1B46-409B-BF8A-66F402192CB8Q51316456-24499EB2-85EF-4E64-BCE5-6DC60C89DDEB
P2860
Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pharmacological inhibition of ...... orylation of residues 216/279.
@en
type
label
Pharmacological inhibition of ...... orylation of residues 216/279.
@en
prefLabel
Pharmacological inhibition of ...... orylation of residues 216/279.
@en
P50
P356
P1476
Pharmacological inhibition of ...... horylation of residues 216/279
@en
P2093
P2860
P304
P356
10.1002/JNR.21523
P50
P577
2008-02-01T00:00:00Z